Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Repligen reported $1.94B in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.

Equity Capital And Reserves Change
Agilent A:US USD 5.78B 172M
Align Technology ALGN:US USD 3.48B 121.31M
Bio Techne TECH:US USD 1.89B 62.58M
BioMarin Pharmaceutical BMRN:US USD 4.66B 55.89M
Bruker BRKR:US USD 1.2B 85M
Catalent CTLT:US USD 4.91B 212M
Charles River Laboratories CRL:US USD 3.11B 132.3M
Danaher DHR:US USD 51.48B 1.4B
Dentsply International XRAY:US USD 3.64B 170M
Exact Sciences EXAS:US USD 3.06B 14.55M
General Electric GE:US USD 31.65B 4.71B
Henry Schein HSIC:US USD 3.47B 26M
Illumina ILMN:US USD 6.69B 94M
IQVIA Holdings Inc IQV:US USD 5.93B 167M
Mettler Toledo International MTD:US USD -24469000 49.26M
Myriad Genetics MYGN:US USD 835.2M 50.6M
NanoString Technologies NSTG:US USD 13.62M 32.19M
OraSure Technologies OSUR:US USD 394.18M 30.56M
Pacific Biosciences Of California PACB:US USD 692.12M 129.21M
Patterson Companies PDCO:US USD 1.1B 60.4M
Peregrine Pharmaceuticals PPHM:US USD 185.4M 4.2M
Repligen RGEN:US USD 1.94B 29.79M
Thermo Fisher Scientific TMO:US USD 42.31B 1.72B
Waters WAT:US USD 599.82M 95.34M
West Pharmaceutical Services WST:US USD 2.78B 91.3M